 |
Dr. Eyal Dassau
Senior Investigator & Diabetes Team Research Manager
Gust Investigator Sansum Diabetes Research Institute (SDRI)
Education
- BSc: 1999, ChE, Technion Israel Institute of Technology
- MSc: 2002, ChE, Technion Israel Institute of Technology
- PhD: 2006, ChE, Technion Israel Institute of Technology
Honors
- Otis William Postdoctoral Fellowship, 2008
Research
- Biomedical design and control: the application of process system engineering principles to design and control of automated insulin delivery system (artificial pancreatic β-cell) to improve glycemic control in type 1 diabetes mellitus patients
- Process and product design with emphasis on medical and biomedical applications
- Systems theory, modeling, simulation, optimization and control to medical, biological, and other complex systems
Publications (selected)
- E. Dassau, C. C. Palerm, H. Zisser, B. A. Buckingham, L. Jovanovič and F. J. Doyle III (2009). “In Silico Evaluation Platform for Artificial Pancreatic b-Cell Development – a Dynamic Simulator for Closed-Loop Control with Hardware-in-the-Loop”, Diabetes Technol. Ther. 11(3),187-194.
- Y. Wang, E. Dassau and F. J. Doyle III (2009). “mproved Glycemic Control in Type 1 Diabetes Mellitus Using Iterative Learning Model Predictive Control”, IEEE Trans. Biomed. Eng. (In Press).
- C. Ellingsen, E. Dassau, H. Zisser, B. Grosman, M. W. Percival, L. Jovanovič , and F. J. Doyle III (2009). “Safety constraints in an artificial b-cell: an implementation of Model Predictive Control (MPC) with Insulin-on-Board (IOB)”, Diabetes Sci. Technol. 3(3), 536-544.
- M. W. Percival, E. Dassau., H. Zisser, L. Jovanovič and F. J. Doyle III (2009). “Closed-Loop Control of an Artificial Pancreatic b-Cell: a Practical Approach to Design and Implementation”, Ind. Eng. Chem. Res. (In Press).
- S. D. Patek, B. W. Bequette, M. Breton, B. A. Buckingham, E. Dassau, F. J. Doyle III, John Lum, L. Magni, and H. Zisser (2009). “In Silico Preclinical Trials: Methodology and Engineering Guide to Closed-Loop Control in T1DM”, Diabetes Sci. Technol. 3(2), 269-282.
- J. Bondia, E. Dassau, H. Zisser, R. Calm, J. Vehí, L. Jovanovič, and F. J. Doyle III (2009). “Coordinated basal-bolus infusion for tighter postprandial glucose control in insulin pump therapy”, Diabetes Sci Technol 3(1), 89-97.
- E. Dassau, H. Zisser, C. C. Palerm, B. A. Buckingham, L. Jovanovič, and F. J. Doyle III (2008). “Modular Artificial β-Cell System: A Prototype for Clinical Research”, Diabetes Sci Technol 2(5), 863-872.
- H. Zisser, L. Robinson, W. Bevier, E. Dassau, C. Ellingsen, F.J. Doyle III and L. Jovanovič (2008). “Bolus Calculator: A Review of Four “Smart” Insulin Pumps.” Diabetes Technol Ther 10(6),441-444.
- E. Dassau, B. W. Bequette, B. A. Buckingham and F. J. Doyle III (2008). “Detection of a Meal Using Continuous Glucose Monitoring (CGM): Implications for an Artificial β-cell.” Diabetes Care 31(2), 295-300.
News
Contact Information
Chemical Engineering Dept.
Mail Code 5080
University of California
Santa Barbara, CA 93106-5080 USA
Office Location: 3228 Engineering II
dassau@engineering.ucsb.edu
Phone: (805)893-8151 / 3120
Fax: (805)893-4731
Links
|
 |